UNLOCKING LEGALITIES: Think Twice About Corrective Measures If You Have Devices With ‘Abnormal Potential For Damage’
This article was originally published in Clinica
Executive Summary
Do you manufacture or sell devices with an “abnormal potential for damage”? Chances are that many companies are just not sure. Here, Erik Vollebregt, partner at Axon Lawyers, explains to Amanda Maxwell what companies can learn from the preliminary ruling by the Court of Justice of the EU in the Boston Scientific/Guidant case involving cardiac implants, and about damage mitigation
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.